Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, ...
More details